At a glance
- Originator Nippon Kayaku
- Class Antiasthmatics; Naphthyridines
- Mechanism of Action Neurokinin 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 18 Dec 2003 No development reported - Preclinical for Asthma in Japan (unspecified route)
- 28 Mar 2001 NK 5807 is available for licensing (http://www.tokyoweb.or.jp/NIPPONKAYAKU/)
- 28 Mar 2001 Preclinical development for Asthma in Japan (unspecified route)